Kratom Compound Mitragynine Plus Naltrexone Cuts Alcohol Consumption More Than Either Drug Alone in Animal Study

Why it matters

Alcohol use disorder (AUD) remains one of the most treatment-resistant conditions in medicine, with existing FDA-approved therapies working poorly for many patients. This first-of-its-kind rat study suggests that combining the kratom alkaloid mitragynine with naltrexone may open a new treatment avenue — one that outperforms either drug alone.

The big picture

Naltrexone, a mu-opioid antagonist already FDA-approved for AUD, reduces alcohol craving but has limited efficacy and poor compliance in many patients. Mitragynine, kratom primary alkaloid, has shown preliminary effects on alcohol consumption in animal models, but its mechanism remains debated. This University of Houston and Baylor College of Medicine study is the first to directly test the combination in female rats, a population underrepresented in AUD pharmacology research.

Key findings

• Mitragynine alone significantly reduced alcohol self-administration in female Sprague-Dawley rats at 1.0 and 3.0 mg/kg doses
• Naltrexone alone also reduced alcohol self-administration; mitragynine was actually more potent than naltrexone at matched doses
• The mitragynine plus naltrexone combination produced a greater reduction than either drug alone — contrary to the researchers hypothesis that naltrexone would block mitragynine effects
• Neither drug nor their combination depressed locomotor activity, ruling out non-specific sedation as an explanation
• The combination increased cFos brain activity markers in reward-relevant regions more than either drug alone, suggesting synergistic neurological effects
• Findings suggest mitragynine may work through mechanisms beyond the mu-opioid system, warranting further pharmacological investigation

What they say

The authors state: "MG decreased alcohol reinforcement more than NTX but the combination of the two was more impactful than either alone and engendered no adverse effects... These data suggest that MG has a complex pharmacology that may involve mechanisms other than the mu opioid system."

Bottom line

A kratom alkaloid combined with naltrexone may reduce alcohol drinking more effectively than current approved treatments — a finding that warrants human clinical investigation.